Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. The Lancet. 2007;370:890–907.
Article
CAS
Google Scholar
McLaughlin-Drubin ME, Munger K. Viruses Associated with Human Cancer. Biochim Biophys Acta. 2008;1782:127–50.
Article
PubMed Central
CAS
PubMed
Google Scholar
IARC Monographs on the evaulation of carcinogenic risks to humans. 2012. http://monographs.iarc.fr/ENG/Monographs/vol100B/mono100B.pdf (Accessed 9/7/2014)
Wheeler CM, Castellsagué X, Garland SM, Szarewski A, Paavonen J, Naud P, et al. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13:100–10.
Article
CAS
PubMed
Google Scholar
Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis. 2010;10:862–74.
Article
PubMed
Google Scholar
Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, et al. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen-and-treat strategies. Int J Cancer J Int Cancer. 2012;130:2111–7.
Article
CAS
Google Scholar
Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters. 2008;16:41–9.
Article
PubMed
Google Scholar
Awodele O, Adeyomoye AAA, Awodele DF, Kwashi V, Awodele IO, Dolapo DC. A Study on Cervical Cancer Screening Amongst Nurses in Lagos University Teaching Hospital, Lagos, Nigeria. J Cancer Educ. 2011;26:497–504.
Article
PubMed Central
CAS
PubMed
Google Scholar
Becker-Dreps S, Otieno WA, Brewer NT, Agot K, Smith JS. HPV vaccine acceptability among Kenyan women. Vaccine. 2010;28:4864–7.
Article
PubMed Central
PubMed
Google Scholar
Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer. 2004;90:638–45.
Article
PubMed Central
CAS
PubMed
Google Scholar
Okolo C, Franceschi S, Adewole I, Thomas JO, Follen M, Snijders PJ, et al. Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infect Agent Cancer. 2010;5:24.
Article
PubMed Central
PubMed
Google Scholar
Nigeria Demographic and Health Survey 2013 {FR293] - FR293.pdf. http://dhsprogram.com/pubs/pdf/FR293/FR293.pdf (Accessed on 17/07/2015)
Ajuwon AJ, Olaleye A, Faromoju B, Ladipo O. Sexual behavior and experience of sexual coercion among secondary school students in three states in North Eastern Nigeria. BMC Public Health. 2006;6:310.
Article
PubMed Central
PubMed
Google Scholar
Kyari O, Nggada H, Mairiga A. Malignant tumours of female genital tract in North Eastern Nigeria. East Afr Med J. 2004;81:142–5.
Article
CAS
PubMed
Google Scholar
Audu BM, Bukar M, Ibrahim AI, Swende TZ. Awareness and perception of human papilloma virus vaccine among healthcare professionals in Nigeria. J Obstet Gynaecol. 2014;34:714–7.
Article
CAS
PubMed
Google Scholar
Evans MF, Adamson CS, Simmons-Arnold L, Cooper K. Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus. BMC Clin Pathol. 2005;5:10.
Article
PubMed Central
PubMed
Google Scholar
Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, et al. Improved Amplification of Genital Human Papillomaviruses. J Clin Microbiol. 2000;38:357–61.
PubMed Central
CAS
PubMed
Google Scholar
Auwal IK, Aminu M, Atanda AT, Tukur J, Sarkinfada F. Prevalence and Risk Factors of High Risk Human Papillomavirus Infections among Women Attending Gynaecology Clinics in Kano, Northern Nigeria. Bayero J Pure Appl Sci. 2014;6:67–71.
Article
Google Scholar
Ezechi OC, Ostergren PO, Nwaokorie FO, Ujah IA, Pettersson KO. The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women. Virol J. 2014;11:5.
Article
PubMed Central
PubMed
Google Scholar
AdegbesanOmilabu M, Okunade K, Omilabu S. Oncogenic human papilloma virus infection among women attending the cytology clinic of a tertiary hospital in Lagos, South-West Nigeria. Int J Res Med Sci. 2014;2:625.
Article
Google Scholar
Akarolo-Anthony SN, Al-Mujtaba M, Famooto AO, Dareng EO, Olaniyan OB, Offiong R, et al. HIV associated high-risk HPV infection among Nigerian women. BMC Infect Dis. 2013;13:521.
Article
PubMed Central
PubMed
Google Scholar
National Population Commission (NPC) [Nigeria] and ICF International. 2014. Nigeria Demographic and Health Survey 2013. Abuja, Nigeria, and Rockville, Maryland, USA: NPC and ICF International.
Didelot-Rousseau M-N, Nagot N, Costes-Martineau V, Vallès X, Ouedraogo A, Konate I, et al. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer. 2006;95:355–62.
Article
PubMed Central
CAS
PubMed
Google Scholar
De Vuyst H, Steyaert S, Van Renterghem L, Claeys P, Muchiri L, Sitati S, et al. Distribution of Human Papillomavirus in a Family Planning Population in Nairobi, Kenya. Sex Transm Dis. 2003;30:137–42.
Article
PubMed
Google Scholar
Salih MM, Safi ME, Hart K, Tobi K, Adam I. Genotypes of human papilloma virus in Sudanese women with cervical pathology. Infect Agent Cancer. 2010;5:26.
Article
PubMed Central
PubMed
Google Scholar
Zandi K, Eghbali SS, Hamkar R, Ahmadi S, Ramedani E, Deilami I, et al. Prevalence of various Human Papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (South west of Iran) 2008–2009. Virol J. 2010;7:65.
Article
PubMed Central
PubMed
Google Scholar
Zhao F-H, Forman MR, Belinson J, Shen Y, Graubard BI, Patel AC, et al. Risk factors for HPV infection and cervical cancer among unscreened women in a high-risk rural area of China. Int J Cancer J Int Cancer. 2006;118:442–8.
Article
CAS
Google Scholar
Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara-Nazos P, Labropoulou V, et al. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol. 1993;67:6424.
PubMed Central
CAS
PubMed
Google Scholar
Orozco-Colín A, Carrillo-García A, Méndez-Tenorio A, Ponce-de-León S, Mohar A, Maldonado-Rodríguez R, et al. Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology. Int J Infect Dis. 2010;14:e1082–7.
Article
PubMed
Google Scholar
Bruni L, Diaz M, Castellsagué M, Ferrer E, Bosch FX, de Sanjosé S. Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings. J Infect Dis. 2010;202:1789–99.
Article
PubMed
Google Scholar
Galloway DA. Is vaccination against human papillomavirus a possibility? Lancet. 1998;351 Suppl 3:22–4.
Article
PubMed
Google Scholar
Li J, Cai H, Xu Z, Wang Q, Hang D, Shen N, et al. Nine Complete Genome Sequences of Cutaneous Human Papillomavirus Genotypes Isolated from Healthy Skin of Individuals Living in Rural He Nan Province, China. J Virol. 2012;86:11936–6.
Canuti M, Deijs M, Jazaeri Farsani SM, Holwerda M, Jebbink MF, de Vries M, et al. Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a γ-papillomavirus. Virology. 2014;5:347.
Google Scholar
Carvalho Nde O, del Castillo DM, Perone C, Januário JN, Melo VH, Brasileiro Filho G. Comparison of HPV genotyping by type-specific PCR and sequencing. Mem Inst Oswaldo Cruz. 2010;105:73–8.
Article
PubMed
Google Scholar
Cai YP, Yang Y, Zhu BL, Li Y, Xia XY, Zhang RF, et al. Comparison of human papillomavirus detection and genotyping with four different prime sets by PCR-sequencing. Biomed Environ Sci BES. 2013;26:40–7.
CAS
PubMed
Google Scholar
Giorgi Rossi P, Bisanzi S, Paganini I, Di Iasi A, Angeloni C, Scalisi A, et al. Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study. BMC Infect Dis. 2010;10:214.
PubMed Central
PubMed
Google Scholar
Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine. 2008;26 Suppl 10:K17–28.
Article
PubMed Central
PubMed
Google Scholar
Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet. 2012;285:771–7.
Article
PubMed
Google Scholar
Chang IJ, Huang R, He W, Zhang S-K, Wang S-M, Zhao F-H, et al. Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: a cross-sectional study. BMC Public Health. 2013;13:916.
Article
PubMed Central
PubMed
Google Scholar
Rocha-Brischiliari SC, Gimenes F, de Abreu ALP, Irie MM, Souza RP, Santana RG, et al. Risk factors for cervical HPV infection and genotypes distribution in HIV-infected South Brazilian women. Infect Agent Cancer. 2014;9:6.
Article
PubMed Central
PubMed
Google Scholar
Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev. 1997;6:799–805.
CAS
PubMed
Google Scholar
Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 2011;12:663–72.
Article
PubMed Central
PubMed
Google Scholar